Structural Heart Disease

Structural heart disease refers to any abnormality or dysfunction of the heart's structures, such as the valves, chambers, or septum.

Traditionally, invasive surgical procedures were the primary treatment option for these conditions, but minimally invasive techniques have rapidly advanced and continue to evolve.

We are the first institution on the West Coast to bring robotically assisted interventions into the catheterization lab, and we are involved in clinical trials studying the safety and efficacy of Transcatheter Aortic Valve Replacement and the Edwards Transcatheter Atrial Shunt System.

We are leaders in percutaneous aortic and mitral valve repair and replacement procedures, such as MitraClip procedures for mitral valve regurgitation and TAVR for aortic stenosis.